Landscapes / Companies
Neurotech Pharmaceuticals not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
1
in active trials · 2 in all
Trials
2 active
11 since 2021
Drugs1
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Approved | 1 May 2028Phase 3 trial completes | |||
| Next date | 1 May 2028 · Phase 3 trial completes | ||||
| Also tested for | Macular Telangiectasia Type 2, Macular Telangiectasia Type 2 (MacTel) | ||||
| Open drug page | |||||
About
- No active trial
- NT-503-3
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021